This study provides a comprehensive molecular and bioinformatics analysis of the CUL3 E3 ubiquitin ligase complex and its regulatory partners in vitiligo, integrating clinical, gene expression, and in silico docking data to elucidate the mechanisms underlying melanocyte loss and immune dysregulation. This evidence concerns the gene CUL3 and vitiligo.